Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Explore how volatility affects retirees in index funds and what tactics—like rebalancing and withdrawal rules—can help manage risk.
23,516 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Oil prices push above $102 per barrel as reports surface that Saudi Arabia and the UAE are weighing deeper involvemen...
Scotiabank boosted Cameco's price target to $175 as a global push for nuclear power gains traction and a new supply d...
Space investing has moved from hype to real dollars. This deep dive compares Intuitive Machines and MDA Space to help...
The Senate Banking Committee kicks off markup on the Digital Asset Market Clarity Act as amendments mount and ethics ...
Investors are hearing bold predictions about rapid crypto gains. This article breaks down how such moves could happen...
The world runs on chips, and ON Semiconductor sits at an important crossroads of EVs, automation, and data centers. T...
Fame brings attention and money, but resilience and smart planning separate long-term winners from flash-in-the-pan s...
Cardano’s ADA dropped sharply, slipping below $0.20 as risk-off sentiment gripped crypto markets. A high-profile upda...
A sharp Friday drop in the Teucrium 2x Long Daily XRP ETF underscores how daily-reset leverage can amplify losses in ...
SoFi Technologies has dropped about 42% over the last six months, trading near $16 as market conditions tighten. Anal...
Saia stock swooned this week after a high-profile downgrade rattled traders, even as some metrics showed resilience. ...